CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 62 filers reported holding CYTOSORBENTS CORP in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,821,112 | -47.2% | 1,502,696 | +0.9% | 0.00% | -40.0% |
Q2 2023 | $5,344,236 | +2.1% | 1,488,645 | -3.8% | 0.01% | 0.0% |
Q1 2023 | $5,232,629 | +124.8% | 1,547,923 | +1.2% | 0.01% | +150.0% |
Q4 2022 | $2,327,445 | +16.2% | 1,529,095 | +3.3% | 0.00% | 0.0% |
Q3 2022 | $2,003,000 | -31.4% | 1,479,570 | +11.4% | 0.00% | -33.3% |
Q2 2022 | $2,918,000 | -26.7% | 1,328,270 | +6.1% | 0.00% | 0.0% |
Q1 2022 | $3,980,000 | -24.3% | 1,251,812 | -0.3% | 0.00% | -25.0% |
Q4 2021 | $5,259,000 | -48.5% | 1,256,068 | -0.4% | 0.00% | -55.6% |
Q3 2021 | $10,203,000 | +59.6% | 1,260,574 | +48.8% | 0.01% | +50.0% |
Q2 2021 | $6,394,000 | -14.4% | 847,089 | -1.9% | 0.01% | -14.3% |
Q1 2021 | $7,471,000 | +2.8% | 863,814 | -5.4% | 0.01% | -12.5% |
Q4 2020 | $7,270,000 | +56.5% | 913,149 | +56.7% | 0.01% | +33.3% |
Q3 2020 | $4,645,000 | – | 582,594 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |